<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive Patent License: Composition and Methods for Delivering Inhibitory Oligonucleotides for the Treatment of Pancreatic Cancer</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive Patent License: Composition and Methods for Delivering Inhibitory Oligonucleotides for the Treatment of Pancreatic Cancer</h1>
    <p class="timestamp">Published: 2017-07-10 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The National Institute on Aging, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the U.S. Patents and Patent Applications listed in the Supplementary Information section of this notice to VeriLuce Therapeutics ("VLT") located in Toronto, ON, Canada.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2017-14370</p>
    <p><strong>Publication Date:</strong> 2017-07-10</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/07/10/2017-14370/prospective-grant-of-exclusive-patent-license-composition-and-methods-for-delivering-inhibitory">https://www.federalregister.gov/documents/2017/07/10/2017-14370/prospective-grant-of-exclusive-patent-license-composition-and-methods-for-delivering-inhibitory</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-14370</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
